...
首页> 外文期刊>Cell metabolism >Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo
【24h】

Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo

机译:人透明细胞肾细胞癌的同位素描绘证明体内抑制葡萄糖氧化

获取原文
获取原文并翻译 | 示例
           

摘要

Clear cell renal cell carcinoma (ccRCC) is the most common form of human kidney cancer. Histological and molecular analyses suggest that ccRCCs have significantly altered metabolism. Recent human studies of lung cancer and intracranial malignancies demonstrated an unexpected preservation of carbohydrate oxidation in the tricarboxylic acid (TCA) cycle. To test the capacity of ccRCC to oxidize substrates in the TCA cycle, we infused C-13-labeled fuels in ccRCC patients and compared labeling patterns in tumors and adjacent kidney. After infusion with [U-C-13] glucose, ccRCCs displayed enhanced glycolytic intermediate labeling, suppressed pyruvate dehydrogenase flow, and reduced TCA cycle labeling, consistent with the Warburg effect. Comparing C-13 labeling among ccRCC, brain, and lung tumors revealed striking differences. Primary ccRCC tumors demonstrated the highest enrichment in glycolytic intermediates and lowest enrichment in TCA cycle intermediates. Among human tumors analyzed by intraoperative C-13 infusions, ccRCC is the first to demonstrate a convincing shift toward glycolytic metabolism.
机译:透明细胞肾细胞癌(CCRCC)是最常见的人肾癌形式。组织学和分子分析表明CCRCC具有显着改变的代谢。最近对肺癌和颅内恶性肿瘤的人类研究表明了三羧酸(TCA)循环中的碳水化合物氧化意外保存。为了测试CCRCC在TCA循环中氧化底物的容量,我们在CCRCC患者中脱氧了C-13标记的燃料,并比较了肿瘤和邻近肾脏的标记图案。用[U-C-13]葡萄糖输注后,CCRCC显示出增强的糖酵解中间标记,抑制丙酮酸脱氢酶流动,降低TCA循环标记,与Warburg效应一致。 C-13在CCRCC,脑和肺肿瘤中的标记揭示了惊人的差异。原发性CCRCC肿瘤证明了糖酵解中间体和TCA循环中间体中最低富集的最高富集。在通过术中C-13输注分析的人肿瘤中,CCRCC是第一个证明甘醇代谢的令人信服的转变。

著录项

  • 来源
    《Cell metabolism》 |2018年第5期|共10页
  • 作者单位

    Univ Texas Southwestern Med Ctr Dallas Dept Internal Med Dallas TX 75390 USA;

    Univ Texas Southwestern Med Ctr Dallas Childrens Med Ctr Res Inst Dallas TX 75390 USA;

    Univ Texas Southwestern Med Ctr Dallas Harold C Simmons Comprehens Canc Ctr Dallas TX 75390 USA;

    Univ Texas Southwestern Med Ctr Dallas Adv Imaging Res Ctr Dallas TX 75390 USA;

    Univ Texas Southwestern Med Ctr Dallas Dept Internal Med Dallas TX 75390 USA;

    Univ Texas Southwestern Med Ctr Dallas Adv Imaging Res Ctr Dallas TX 75390 USA;

    Univ Texas Southwestern Med Ctr Dallas Dept Urol Dallas TX 75390 USA;

    Univ Texas Southwestern Med Ctr Dallas Harold C Simmons Comprehens Canc Ctr Dallas TX 75390 USA;

    Univ Texas Southwestern Med Ctr Dallas Kidney Canc Program Dallas TX 75390 USA;

    Univ Texas Southwestern Med Ctr Dallas Dept Urol Dallas TX 75390 USA;

    Univ Texas Southwestern Med Ctr Dallas Dept Urol Dallas TX 75390 USA;

    Univ Texas Southwestern Med Ctr Dallas Dept Urol Dallas TX 75390 USA;

    Univ Texas Southwestern Med Ctr Dallas Kidney Canc Program Dallas TX 75390 USA;

    Univ Texas Southwestern Med Ctr Dallas Childrens Med Ctr Res Inst Dallas TX 75390 USA;

    Univ Texas Southwestern Med Ctr Dallas Dept Internal Med Dallas TX 75390 USA;

    Univ Texas Southwestern Med Ctr Dallas Dept Internal Med Dallas TX 75390 USA;

    Univ Texas Southwestern Med Ctr Dallas Dept Internal Med Dallas TX 75390 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 内分泌腺疾病及代谢病;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号